Elkfork Partners’s aTyr Pharma ATYR Stock Holding History

Elkfork Partners’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$25K	Sell	7,062 -20	-0.3%	-$74	﹤0.01%	1019
2019 Q2	$36K	Hold	7,082	–	–	﹤0.01%	1007
2019 Q1	$55K	Hold	7,082	–	–	﹤0.01%	980
2018 Q4	$49K	Hold	7,082	–	–	﹤0.01%	949
2018 Q3	$81K	Hold	7,082	–	–	﹤0.01%	970
2018 Q2	$90K	Hold	7,082	–	–	﹤0.01%	941
2018 Q1	$263K	Hold	7,082	–	–	0.01%	713
2017 Q4	$347K	Hold	7,082	–	–	0.01%	643
2017 Q3	$501K	Hold	7,082	–	–	0.01%	489
2017 Q2	$342K	Hold	7,082	–	–	0.01%	576
2017 Q1	$347K	Sell	7,082 -1,225	-15%	-$56K	0.01%	515
2016 Q4	$250K	Buy	+8,307	New	+$341K	0.01%	531

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GHCM

Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return

MCIM

Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return

Elkfork Partners's ATYR Position: Q3 2019 in Review

Elkfork Partners reduced its aTyr Pharma (ATYR) stake by 0.28% in Q3 2019, selling an estimated $74 and leaving 7,062 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #1019.

Elkfork Partners first reported a position in ATYR in Q4 2016 and has held it in 12 quarters since. The position peaked at $501K in Q3 2017. 19 funds tracked by Wall St. Rank hold ATYR as of Q3 2019.

Elkfork Partners held 7,062 shares of aTyr Pharma worth $25K as of Q3 2019.
Elkfork Partners sold 20 aTyr Pharma shares in Q3 2019, an estimated $74.
aTyr Pharma made up ﹤0.01% of Elkfork Partners's portfolio in Q3 2019, its #1019 holding.
Elkfork Partners first reported a position in aTyr Pharma in Q4 2016 and has held it in 12 quarters since.
Elkfork Partners's aTyr Pharma position peaked at $501K in Q3 2017.
19 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.